Yamanouchi Pharmaceutical Company Ltd.

Yoshiaki Soeishi

Saburo Higuchi

Hiroitsu Kawata

Masayoshi Aruga

Tadayoshi Ohmura

Muneo Fukui

Atsushi Kajiyama

Katsuhiko Yano

Tamio Hikosaka

Shigeru Masuyama

Mikio Matsumura

Kouji Tomuro

A pharmaceutical controlled-release individual unit or multiple units formulation in which the individual unit comprises a granulation product obtained by adding a release controlling agent to a mixture of a physiologically active substance and units-forming substance(s) and granulating and resultant mixture, said granulation product (granules) being substantially not disintegrated but gradually releasing the physiologically active substance in the gastrointestinal tract.

Controlled-release multiple units pharmaceutical formulation

A novel nifedipine-containing solid pharmaceutical preparation composition comprising a mixture of nifedipine and at least one 1st(a) substance selected from polyvinyl pyrrolidone, methyl cellulose, hydroxypropyl cellulose and hydroxypropylmethyl cellulose; a mixture of nifedipine, at least one 1st(b) substance selected from polyvinyl pyrrolidone, urea, citric acid mannitol, succinic acid, methyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose and amino acid, and at least one 2nd substance selected from a surface active agent, polyethylene glycol, propylene glycol, glycerol, a glycerol fatty acid ester and a vegetable oil; or a mixture of nifedipine, the 1st(b) substance, the 2nd substance and calcium lactate. The composition of this invention can increase the bioavailability of nifedipine and makes it possible to provide a nifedipine-containing pharmaceutical preparation which has small bulk and can be easily administered.

Nifedipine-containing solid preparation composition

Growing community of inventors

Tokyo, Japan

Yoshiaki Soeishi